|
Pharmaceutical Outsourcing Part
2: An Introduction to Drug Discovery Strategies – new
opportunities lie in a fully integrated global outsourcing
strategy
The pharma industry is facing a crisis over R&D productivity, as reflected by the low level of new drug approvals despite companies investing the highest ever amounts in R&D. As a result, companies are seeking novel ways to drive growth, with many opting to increase their reliance on third parties - through licensing, collaborative and outsourcing agreements - in an attempt to achieve this.
View
Table Of Contents >
|
